Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: Recent trends
✍ Scribed by Peter Jepsen; Hendrik Vilstrup; Robert E. Tarone; Søren Friis; Henrik Toft Sørensen
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 184 KB
- Volume
- 121
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Hepatocellular carcinoma (HCC) incidence rates vary by gender, age, time and place. Geographic differences in gender‐, age‐ and time‐specific HCC incidence rates may improve the understanding of HCC risk factors. We computed annual standardized HCC incidence rates for the United States (U.S.) 1978–2004 and for Denmark 1978–2003. Among U.S. white men aged 45–59 the HCC incidence rates were comparable to the Danish rates until 1995, but more than tripled over the following 8 years to become over 2.5‐fold higher than the Danish rate by 2003, with an additional small increase in 2004. HCC rates in black U.S. men aged 45–59 also increased sharply after 1995. Among women aged 45–59 the U.S. HCC rates were elevated in recent years, but did not show the sharp increase after 1995 observed among men; the Danish rates showed a decreasing trend throughout 1978–2003. U.S. rates in the 60–74 years age groups showed a protracted and gradual increase with no evidence of a sharp increase after 1995. In the 60–74 years age group, rates for Danish men were comparable to those for U.S. white men, but rates for Danish women decreased. The U.S. prevalence rates of hepatitis C virus (HCV) infection are 2.1 and 1.1% for men and women, respectively, the Danish 0.2%. The disparity in HCV prevalence is the most likely explanation for the differences between Danish and U.S. trends in HCC incidence. Intravenous drug use and blood transfusions are the major sources of HCV, and we suggest that increased HCV infection prevalence among Vietnam era military veterans may contribute to the earlier and steeper HCC incidence increase for U.S. men than for U.S. women. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Background: Prostate carcinoma incidence has been declining since 1992 after a period of marked increase. recent data from the national cancer data base (ncdb) were examined to assess changes in prostate carcinoma patient characteristics and disease and treatment patterns coincidental to this de
## Abstract ## BACKGROUND The rapid increase in the incidence of ductal carcinoma in situ (DCIS) of the breast in the U.S. has been associated with the widespread adoption of screening mammography. Little is known regarding the incidence and treatment of DCIS in women of racial/ethnic groups other
## BACKGROUND. Colon carcinoma incidence rates have risen sharply over the second half of this century, particularly among males and blacks. In the late 1970s, incidence rates among whites began to decline for distant disease. Approximately 10 years later regional disease rates began to fall. The d
## Abstract We examined trends in the incidence and mortality, and described the survival of patients with penile squamous cell carcinoma in the Netherlands between 1989 and 2006. On the basis of nationwide population‐based data, 3‐year moving average European age‐standardized incidence and 10‐year